Lung Small Cell Carcinoma

general

A highly aggressive carcinoma with neuroendocrine differentiation that arises from the lung. It is characterized by the presence of malignant small cells and more than 10 mitoses per 2 mm2. Necrosis is frequently seen. Metastatic disease is usually present at the time of diagnosis.

74

Centers

243

Active Trials

$7.2B

Cancer Funding

Specific Cancer Types(4)

Top Centers for Lung Small Cell Carcinoma(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
67.0
2
NCI Comprehensive
Active Research Program
67.0
3
NCI Comprehensive
Active Research Program
67.0
4
NCI Comprehensive
Active Research Program
67.0
5
NCI Comprehensive
Active Research Program
67.0
6
NCI Comprehensive
Active Research Program
67.0
7
NCI Comprehensive
Active Research Program
67.0
8
Active Research Program
67.0
9
NCI Clinical
Active Research Program
67.0
10
Active Research Program
67.0
11
Active Research Program
67.0
12
Active Research Program
67.0
13
Active Research Program
67.0
14
Active Research Program
67.0
15
Active Research Program
67.0
16
NCI Comprehensive
Active Research Program
44.5
17
NCI Comprehensive
Active Research Program
44.5
18
NCI Comprehensive
Active Research Program
44.5
19
NCI Comprehensive
Active Research Program
44.5
20
NCI Comprehensive
Active Research Program
44.5
21
NCI Comprehensive
Active Research Program
44.5
22
NCI Comprehensive
Active Research Program
44.5
23
NCI Comprehensive
Active Research Program
44.5
2444.5
25
NCI Comprehensive
Active Research Program
44.5
26
NCI Comprehensive
Active Research Program
44.5
27
NCI Comprehensive
Active Research Program
44.5
28
NCI Comprehensive
Active Research Program
44.5
29
NCI Comprehensive
Active Research Program
44.5
30
NCI Comprehensive
Active Research Program
44.5
31
NCI Comprehensive
Active Research Program
44.5
32
NCI Comprehensive
Active Research Program
44.5
33
NCI Clinical
Active Research Program
44.5
34
Active Research Program
44.5
35
NCI Comprehensive
Active Research Program
44.5
36
NCI Comprehensive
Active Research Program
44.5
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
44.5
38
NCI Clinical
Active Research Program
44.5
39
NCI Comprehensive
Active Research Program
44.5
40
Active Research Program
44.5
41
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
44.5
42
Active Research Program
44.5
4344.5
44
Active Research Program
44.5
45
Active Research Program
44.5
46
Active Research Program
44.5
47
Active Research Program
44.5
4844.5
49
Active Research Program
44.5
50
Active Research Program
44.5
51
BC CancerVancouver, BC
Active Research Program
44.5
52
Active Research Program
44.5
53
NCI Comprehensive
54
55
NCI Comprehensive
56
NCI Comprehensive
57
NCI Comprehensive
58
NCI Comprehensive
59
NCI Comprehensive
60
NCI Comprehensive
61
62
63
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
64
NCI Clinical
65
66
NCI Clinical
67
NCI Comprehensive
68
NCI Comprehensive
69
70
NCI Basic_laboratory
71
72
73
74

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →